Evaluation of brain natriuretic peptide as marker of left ventricular dysfunction and hypertrophy in the population.
Abstract
To evaluate brain natriuretic peptide (BNP) as marker of left ventricular (LV) dysfunction and hypertrophy in a population-based sample of 610 middle-aged subjects (50-67 years) who were further characterized with respect to hemodynamic and anthropometric parameters and by echocardiography.
